Stay Connected

FDA continues on the pathway of smart deregulation of medical devices based on risk assessments

The U.S. Food and Drug Administration (FDA) plans to exempt 120 medical device classes from its premarket notification and review requirements, making it substantially easier for companies to market the devices. – See more at: